Loading company…
Paris-based natural language generation company that automates regulatory and medical document creation for life sciences.
Founded in 2007 and based in Paris, Yseop SAS develops Natural Language Generation technology for life sciences, led by CEO Emmanuel Walckenaer. Its Yseop Copilot product drafts regulatory and medical documents, cutting drafting time from weeks to minutes, for pharmaceutical and biotech clients. It reported revenue of EUR 3,567,354.60 and EBITDA of EUR 587,041.80 in its latest fiscal year and raised EUR 2.05 million in a Series A round in July 2020.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in